BioSpace News Archive

Janssen Pharmaceutical Companies from Johnson & Johnson, confirmed topline data from its Phase III Antiretroviral Therapy as Long-Acting Suppression (ATLAS) trial of its two-drug combination for HIV.

Express Scripts is already known for its role of bringing prescriptions to the doors of consumers. Now the company is moving into a new area of providing medicines—expensive gene therapies.

You’ve done the research, had a great idea, and worked hard to make it a success. However, when the time comes to address the achievement with others in the organization, your boss takes the credit!

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Days after it closed on a $42 million Series A funding round, Karuna Pharmaceuticals has named a new chief executive officer. The company appointed industry veteran and founder of Sage Therapeutics Steven Paul as its new top officer.

On a dollar-for-dollar basis, vaccines have probably had a greater positive effect on global health than any other medical advancement, except possibly antibiotics. Yet as a whole, it’s an area that pharma companies tend to not spend a lot of resources on. But there are still many companies that work in this area. Here’s a look at five promising vaccines.

Foster City, Calif.-based Gilead Sciences reorganized some of its executive leadership team after it was announced that Chief Medical Officer Andrew Cheng is leaving the company to pursue other opportunities.

ALS is a progressive neurodegenerative disease that affects neurons in the brain and the spinal cord. The disease is usually fatal within two to five years of diagnosis. While there is no cure for the disease, multiple companies are working on treatments hoping to be the first to provide a viable option for patients like Scott Hayes. There are some treatments that may provide hope for patients.

Generally speaking, the larger the animal, the more cells they have, the more likely they are to get cancer. The longer an animal lives, even if that animal is a human being, the higher the likelihood of cancer. Except elephants. Elephants rarely get cancer.

RXi Pharmaceuticals, headquartered in Marlborough, Mass., signed a research collaboration deal with Sweden’s Karolinska Institute. They will work to develop cancer therapies using RXi’s sd-rxRNA compounds against targets involved in T-cell and NK cell differentiation.